Overview
Leidos Holdings, Inc., based in the United States, operates primarily within the defense, aviation, information technology, and biomedical research industries. Leidos serves as a pivotal contractor for U.S. government agencies, including the Department of Defense, Homeland Security, and the National Institutes of Health, amongst other commercial and international entities. Key projects undertaken by Leidos encompass a wide range, from providing scientific support for national health initiatives to innovative solutions in cybersecurity and intelligence surveillance reconnaissance (ISR) systems. The company's commitment to leveraging cutting-edge technology and expertise to deliver efficient, comprehensive solutions characterizes its strategic operational approach, allowing it to maintain a leading role in addressing complex challenges across both government and commercial sectors.
Basic Stats
The share price of Leidos Holdings, Inc. as of September 5, 2025 is $178.93 / share. This is a decrease of -1.10% from the prior week. The market cap (or net worth) of Leidos Holdings, Inc. as of September 5, 2025 is $22,956.00 MM.
The Factor Analysis chart (below right) shows a view of Leidos Holdings, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 22,956.00 MM |
| EV | 27,175.00 MM |
| Shares Out. | 128.30 MM |
| Earnings Date | |
| EPS (TTM) | 10.93 |
| Dividend Yield | 0.89 % |
| Ex-Dividend Date | 2025-09-15 |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 1.90 MM |
| Short Interest | 3.42 MM |
| Short Float | 2.69 % |
| Days to Cover | 5.62 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 14.85 % |
| Volatility (1 yr) | 0.31 |
| Beta | 0.64 |
| Sharpe Ratio (1 yr) | 0.34 |
| Sortino Ratio (1 yr) | 0.51 |
| PE Ratio | 16.37 |
| Price/Book | 4.88 |
| Price/TBV | -10.38 |
| Book/Market | 0.21 |
| EBIT/EV | 0.07 |
| EBIT(3yr avg)/EV | 0.04 |
| ROA | 0.11 |
| ROE | 0.31 |
| ROIC | 0.13 |
| CROIC | 0.01 |
| OCROIC | 0.14 |
| Implied Volatility | 20.01 % |
| Put/Call OI Ratio | 1.17 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Leidos Holdings, Inc. is $187.77. The forecasts range from a low of $165.64 to a high of $215.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Leidos Holdings, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-12-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-12-08 | Citigroup | Buy | Initiate | |
| 2022-12-02 | RBC Capital | Sector Perform | Maintains | |
| 2022-11-02 | RBC Capital | Sector Perform | Maintains | |
| 2022-08-30 | RBC Capital | Sector Perform | Initiate | |
| 2022-08-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-08-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-06-08 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2022-06-07 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2022-05-04 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-04-14 | Goldman Sachs | Buy | Maintains | |
| 2022-03-24 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2022-03-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-01 | Goldman Sachs | Buy | Maintains | |
| 2022-01-24 | Barclays | Overweight | Maintains | |
| 2021-11-03 | Wells Fargo | Overweight | Maintains | |
| 2021-08-20 | Argus Research | Buy | Hold | Downgrade |
| 2021-08-04 | Baird | Outperform | Maintains | |
| 2021-06-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-06-02 | Argus Research | Buy | Maintains | |
| 2021-05-13 | Wells Fargo | Overweight | Initiate | |
| 2021-04-05 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2021-03-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-03-03 | B of A Securities | Buy | Maintains | |
| 2021-02-24 | Credit Suisse | Outperform | Maintains | |
| 2020-11-03 | Credit Suisse | Outperform | Maintains | |
| 2020-09-23 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2020-09-22 | JP Morgan | Neutral | Overweight | Upgrade |
| 2020-06-11 | Baird | Outperform | Initiate | |
| 2020-05-11 | Jefferies | Buy | Maintains | |
| 2020-05-07 | Credit Suisse | Outperform | Reiterate | |
| 2020-05-06 | JP Morgan | Neutral | Maintains | |
| 2020-05-04 | Wells Fargo | Overweight | Maintains | |
| 2020-04-14 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-04-02 | Wells Fargo | Overweight | Maintains | |
| 2020-03-31 | William Blair | Outperform | Initiate | |
| 2020-03-24 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-03 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2020-03-02 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2020-02-26 | JP Morgan | Neutral | Maintains | |
| 2020-02-19 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-02-06 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-01-09 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2019-12-23 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-12-18 | Wells Fargo | Overweight | Maintains | |
| 2019-12-18 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2019-12-18 | Credit Suisse | Outperform | Maintains | |
| 2019-10-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-09-24 | JP Morgan | Neutral | Initiate | |
| 2019-09-20 | Barclays | Equal-Weight | Initiate | |
| 2019-08-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-07-09 | Citi | Buy | Neutral | Downgrade |
| 2019-06-03 | Morgan Stanley | Equal-Weight | Initiate | |
| 2018-10-29 | Argus | Buy | Buy | Maintains |
| 2018-06-18 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-02-26 | Citigroup | Buy | Buy | Maintains |
| 2018-02-23 | Credit Suisse | Outperform | Outperform | Maintains |
| 2017-11-03 | Citigroup | Buy | Maintains | |
| 2017-10-25 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2017-08-31 | Argus | Buy | Maintains | |
| 2017-08-10 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2017-03-17 | Vertical Research | Buy | Initiate | |
| 2016-12-14 | Goldman Sachs | Neutral | Initiate | |
| 2016-12-06 | Oppenheimer | Outperform | Initiate | |
| 2016-11-21 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2016-09-07 | Citigroup | Buy | Maintains | |
| 2016-09-07 | Argus | Buy | Initiate | |
| 2016-08-02 | Credit Suisse | Neutral | Maintains | |
| 2016-02-23 | Deutsche Bank | Hold | Maintains | |
| 2015-11-02 | Drexel Hamilton | Hold | Buy | Upgrade |
| 2015-10-29 | BB&T Capital | Hold | Buy | Upgrade |
| 2015-07-28 | BB&T Capital | Hold | Initiate | |
| 2015-05-13 | Citigroup | Buy | Maintains | |
| 2015-03-30 | Jefferies | Hold | Maintains | |
| 2015-03-26 | Credit Suisse | Neutral | Maintains | |
| 2015-03-26 | Citigroup | Buy | Maintains | |
| 2015-01-28 | Wells Fargo | Underperform | Market Perform | Upgrade |
| 2015-01-08 | JP Morgan | Neutral | Underweight | Downgrade |
| 2014-12-12 | Citigroup | Buy | Initiate | |
| 2014-12-09 | Drexel Hamilton | Hold | Initiate | |
| 2014-12-08 | Jefferies | Hold | Maintains | |
| 2014-10-07 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2014-09-15 | Credit Suisse | Underperform | Maintains | |
| 2014-06-05 | JP Morgan | Neutral | Maintains | |
| 2014-03-31 | JP Morgan | Neutral | Maintains | |
| 2013-12-11 | Credit Suisse | Underperform | Maintains | |
| 2023-02-16 | Citigroup | Buy | Maintains | |
| 2023-02-15 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-02-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-15 | RBC Capital | Sector Perform | Maintains | |
| 2023-03-27 | Jefferies | Buy | Hold | Downgrade |
| 2023-05-03 | RBC Capital | Sector Perform | Maintains | |
| 2023-05-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-05-03 | Citigroup | Buy | Maintains | |
| 2023-05-03 | Barclays | Overweight | Maintains | |
| 2023-05-03 | Truist Securities | Buy | Maintains | |
| 2023-05-16 | Stifel | Buy | Buy | Maintains |
| 2023-05-25 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-10-03 | Stifel | Buy | Buy | Maintains |
| 2023-08-03 | Goldman Sachs | Buy | Buy | Maintains |
| 2023-08-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-02 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-08-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-08-02 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-02 | Citigroup | Buy | Buy | Maintains |
| 2023-08-18 | Stifel | Buy | Buy | Maintains |
| 2023-09-18 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-11-17 | Argus Research | Hold | Buy | Upgrade |
| 2023-11-01 | Truist Securities | Buy | Buy | Maintains |
| 2023-11-01 | Stifel | Buy | Buy | Maintains |
| 2024-04-04 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-03-20 | Argus Research | Buy | Buy | Maintains |
| 2024-02-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-14 | Truist Securities | Buy | Buy | Maintains |
| 2024-02-14 | Baird | Outperform | Outperform | Maintains |
| 2024-02-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-03-27 | B of A Securities | Buy | Buy | Maintains |
| 2024-05-01 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-05-01 | Truist Securities | Buy | Buy | Reiterate |
| 2024-05-01 | Stifel | Buy | Buy | Maintains |
| 2024-05-01 | Baird | Outperform | Outperform | Maintains |
| 2024-04-10 | Jefferies | Hold | Hold | Maintains |
| 2024-01-05 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2024-04-09 | Truist Securities | Buy | Buy | Maintains |
| 2024-05-06 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-10 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-06-24 | Stifel | Buy | Buy | Maintains |
| 2024-12-12 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2025-06-24 | Stifel | Buy | Reiterate | |
| 2024-08-05 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-01 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-22 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-30 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-30 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-10-30 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-30 | Citigroup | Buy | Buy | Maintains |
| 2024-10-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-30 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-10-30 | Baird | Outperform | Outperform | Maintains |
| 2024-11-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-08-07 | B of A Securities | Buy | Buy | Maintains |
| 2024-07-31 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-07-31 | Citigroup | Buy | Buy | Maintains |
| 2024-07-31 | TD Cowen | Buy | Buy | Maintains |
| 2024-07-31 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-05-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-05-07 | UBS | Neutral | Neutral | Maintains |
| 2025-02-12 | UBS | Neutral | Neutral | Maintains |
| 2025-02-12 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-12 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-10 | Citigroup | Buy | Buy | Maintains |
| 2024-09-05 | Truist Securities | Buy | Buy | Maintains |
| 2024-12-02 | UBS | Neutral | Initiate | |
| 2025-02-21 | William Blair | Outperform | Market Perform | Downgrade |
| 2024-10-01 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-04 | Barclays | Overweight | Overweight | Maintains |
| 2025-01-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-08 | TD Cowen | Buy | Hold | Downgrade |
| 2025-02-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-14 | Truist Securities | Buy | Buy | Maintains |
| 2025-09-04 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2025-08-06 | Jefferies | Hold | Buy | Upgrade |
| 2025-08-07 | UBS | Neutral | Neutral | Maintains |
| 2025-05-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-14 | Citigroup | Buy | Buy | Maintains |
